Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis
2023-03-06 20:00
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy
2023-03-02 20:00
Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network
2023-03-02 18:00
ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA
2023-03-02 14:09
GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting
2023-03-01 19:00
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND
2023-02-28 23:00
Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference
2023-02-28 21:00
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
2023-02-28 08:53
Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology
2023-02-28 01:00
Gracell Biotechnologies to Report Fourth Quarter 2022 Financials on Monday, March 13, 2023
2023-02-27 21:00
Singleron Biotechnologies and Macrogen Europe announce a strategic alliance
2023-02-27 16:00
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
2023-02-24 20:00
Dr. Lilly Xu Named President of Shanghai ChemPartner
2023-02-24 05:53
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
2023-02-23 13:01
Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration
2023-02-22 22:00
GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate
2023-02-22 21:00
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study
2023-02-22 20:30
Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA
2023-02-22 20:17
Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON
2023-02-21 21:30
NMPA accepted the registration applications for Uro-G and Uro-3500
2023-02-21 17:46
1
59
60
61
62
63
222